专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07793094B2 HTTP cookie protection by a network security device 有权
标题翻译：网络安全设备的HTTP cookie保护
公开(公告)号：US07793094B2
公开(公告)日：2010-09-07
申请号：US11406107
申请日：2006-04-18
申请人： Darshant B. Bhagat , Manjeri Krishnan , Karthikeyan M. Sadhasivam , Ravi K. Varanasi
发明人： Darshant B. Bhagat , Manjeri Krishnan , Karthikeyan M. Sadhasivam , Ravi K. Varanasi
IPC分类号： H04L29/06 , G06F21/00
CPC分类号： H04L63/1441 , H04L63/0435 , H04L63/0471 , H04L63/123 , H04L67/14 , H04L67/146
摘要： An intrusion detection system and method for a computer network includes a processor and one or more programs that run on the processor for application inspection of data packets traversing the computer network. The one or more programs also obtaining attribute information from the packets specific to a particular application and comparing the attribute information against a knowledge database that provides a baseline of normal network behavior. The processor raises an alarm whenever the attribute information exceeds a predetermined range of deviation from the baseline of normal network behavior.
摘要翻译：用于计算机网络的入侵检测系统和方法包括处理器和在处理器上运行的一个或多个程序，用于对遍历计算机网络的数据分组进行应用检查。一个或多个程序还从特定于特定应用的分组中获取属性信息，并将属性信息与提供正常网络行为基准的知识数据库进行比较。每当属性信息超出与正常网络行为的基线偏离的预定范围时，处理器就会发出报警。

2. 发明授权

US08161554B2 System and method for detection and mitigation of network worms 有权
标题翻译：用于网络蠕虫检测和减轻的系统和方法
公开(公告)号：US08161554B2
公开(公告)日：2012-04-17
申请号：US11114575
申请日：2005-04-26
申请人： Karthikeyan M. Sadhasivam , Shuguang Zhang , Ravi K. Varanasi
发明人： Karthikeyan M. Sadhasivam , Shuguang Zhang , Ravi K. Varanasi
IPC分类号： G06F11/00
CPC分类号： H04L63/1425 , H04L63/145
摘要： An intrusion detection system for a computer network includes a knowledge database that contains a baseline of normal host behavior, and a correlation engine that monitors network activity with reference to the knowledge database. The correlation engine accumulating information about anomalous events occurring on the network and then periodically correlating the anomalous events. The correlation engine generates a worm outbreak alarm when a certain number of hosts exhibit a role-reversal behavior. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).
摘要翻译：用于计算机网络的入侵检测系统包括包含正常主机行为的基准的知识数据库，以及参考知识数据库来监视网络活动的相关引擎。相关引擎累积关于在网络上发生的异常事件的信息，然后周期性地关联异常事件。当一定数量的主机出现角色反转行为时，相关引擎会生成蠕虫爆发警报。要强调的是，该摘要被提供以符合要求抽象的规则，允许搜索者或其他读者快速确定技术公开内容的主题。提交它的理解是，它不会用于解释或限制权利要求的范围或含义。 37 CFR 1.72（b）。

3. 发明申请

US20090232743A1 Foamable Microemulsion Compositions for Topical Administration 失效
标题翻译：用于局部管理的可发泡微乳液组合物
公开(公告)号：US20090232743A1
公开(公告)日：2009-09-17
申请号：US12371155
申请日：2009-02-13
申请人： Ravi K. Varanasi , Roman V. Rariy
发明人： Ravi K. Varanasi , Roman V. Rariy
IPC分类号： A61K9/12 , A61K31/164
CPC分类号： A61K9/0014 , A61K9/122 , A61K9/124 , A61K31/164
摘要： Described are ethanol-free foamable microemulsions for topical application, and method of making them. The propellants used in the compositions may be environmentally-friendly hydrofluoroalkanes. The foam compositions may also comprise one or more of a variety of active ingredients, including anti-inflammatory agents, anesthetics, and keratolytic agents.
摘要翻译：描述了用于局部应用的无乙醇泡沫微乳液及其制备方法。在组合物中使用的推进剂可以是环保的氢氟烷烃。泡沫组合物还可以包含一种或多种各种活性成分，包括抗炎剂，麻醉剂和角质分解剂。

4. 发明授权

US08840928B2 Tamper-resistant pharmaceutical compositions of opioids and other drugs 有权
标题翻译：抗疟药物组合物的阿片样物质和其他药物
公开(公告)号：US08840928B2
公开(公告)日：2014-09-23
申请号：US12965572
申请日：2010-12-10
申请人： Roman V. Rariy , Alison B. Fleming , Jane C. Hirsh , Said Saim , Ravi K. Varanasi
发明人： Roman V. Rariy , Alison B. Fleming , Jane C. Hirsh , Said Saim , Ravi K. Varanasi
IPC分类号： A61K9/14 , A61K9/16 , A61K31/44 , A61K9/50 , A61K9/20
CPC分类号： A61K31/485 , A61K9/14 , A61K9/1617 , A61K9/1635 , A61K9/1641 , A61K9/1664 , A61K9/1694 , A61K9/4808 , A61K9/5042 , A61K47/12 , A61K47/44 , B29C70/60
摘要： Tamper-resistant pharmaceutical compositions have been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opioids. The tamper-resistant compositions retard the release of drug, even if the physical integrity of the formulation is compromised (for example, by chopping with a blade or crushing) and the resulting material is placed in water, snorted, or swallowed. However, when administered as directed, the drug is slowly released from the composition as the composition is passes through the GI tract.
摘要翻译：已经开发了防篡改的药物组合物，以减少不适当地施用药物，特别是诸如阿片样物质的药物的可能性。即使制剂的物理完整性受损（例如通过用刀片切碎或破碎），防篡改组合物也能延缓药物的释放，并将所得材料置于水中，嗅到或吞咽。然而，当按照指导给药时，当组合物通过胃肠道时，药物从组合物缓慢释放。

5. 发明授权

US08592380B2 Aerosol foams comprising clindamycin phosphate 有权
标题翻译：含有克林霉素磷酸盐的气溶胶泡沫
公开(公告)号：US08592380B2
公开(公告)日：2013-11-26
申请号：US13053524
申请日：2011-03-22
申请人： Mark W. Trumbore , Wendy Schilling , Ravi K. Varanasi
发明人： Mark W. Trumbore , Wendy Schilling , Ravi K. Varanasi
IPC分类号： A61K31/70 , A61K31/7056 , A61K31/40
CPC分类号： A61K9/12 , A61K9/0014 , A61K31/7056
摘要： Described herein are emulsions and compositions for the treatment of acne vulgaris. The emulsions may be formulated as aerosol compositions. The aerosol propellant may be a hydrofluoroalkane propellant. The emulsions or compositions may comprise clindamycin phosphate and a buffer salt, and may exhibit decreased rates of clindamycin phosphate hydrolysis. Also described are methods of treating acne vulgaris, comprising the step of applying to an affected area of a subject in need thereof a therapeutically-effective amount of an inventive emulsion or aerosol composition.
摘要翻译：本文描述了用于治疗寻常痤疮的乳剂和组合物。乳液可以配制成气溶胶组合物。气溶胶推进剂可以是氢氟烷烃推进剂。乳剂或组合物可以包括磷酸克林霉素和缓冲盐，并且可以表现出降低的克林霉素磷酸酯水解速率。还描述了治疗寻常痤疮的方法，包括向有需要的受试者的受影响区域施用治疗有效量的本发明乳剂或气溶胶组合物的步骤。

6. 发明申请

US20110236321A1 Aerosol Foams Comprising Clindamycin Phosphate 有权
标题翻译：气溶胶泡沫包括克林霉素磷酸盐
公开(公告)号：US20110236321A1
公开(公告)日：2011-09-29
申请号：US13053524
申请日：2011-03-22
申请人： Mark W. Trumbore , Wendy Schilling , Ravi K. Varanasi
发明人： Mark W. Trumbore , Wendy Schilling , Ravi K. Varanasi
IPC分类号： A61K9/12 , A61P17/10 , A61P31/04 , A61P31/10
CPC分类号： A61K9/12 , A61K9/0014 , A61K31/7056
摘要： Described herein are emulsions and compositions for the treatment of acne vulgaris. The emulsions may be formulated as aerosol compositions. The aerosol propellant may be a hydrofluoroalkane propellant. The emulsions or compositions may comprise clindamycin phosphate and a buffer salt, and may exhibit decreased rates of clindamycin phosphate hydrolysis. Also described are methods of treating acne vulgaris, comprising the step of applying to an affected area of a subject in need thereof a therapeutically-effective amount of an inventive emulsion or aerosol composition.
摘要翻译：本文描述了用于治疗寻常痤疮的乳剂和组合物。乳液可以配制成气溶胶组合物。气溶胶推进剂可以是氢氟烷烃推进剂。乳剂或组合物可以包括磷酸克林霉素和缓冲盐，并且可以表现出降低的克林霉素磷酸酯水解速率。还描述了治疗寻常痤疮的方法，包括向有需要的受试者的受影响区域施用治疗有效量的本发明乳剂或气溶胶组合物的步骤。

7. 发明授权

US09065741B1 Methods and apparatuses for identifying and alleviating internal bottlenecks prior to processing packets in internal feature modules 有权
标题翻译：在内部功能模块中处理数据包之前识别和缓解内部瓶颈的方法和设备
公开(公告)号：US09065741B1
公开(公告)日：2015-06-23
申请号：US10672476
申请日：2003-09-25
申请人： Ravi K. Varanasi , Ravishankar Ganeshithal
发明人： Ravi K. Varanasi , Ravishankar Ganeshithal
IPC分类号： H04L12/801 , H04L29/06 , H04L12/911 , H04L12/863 , H04L12/851
CPC分类号： H04L47/12 , H04L47/2441 , H04L47/6215 , H04L47/748 , H04L63/0485
摘要： Methods and apparatuses for identifying and alleviating bottlenecks prior to processing packets in internal feature modules are described. First, a method is provided for aggregating the service policies of various physical interfaces, and using results of the aggregation to determine whether a packet processing engine is capable of satisfying the aggregated service policy information. Second, a method and apparatus for applying the aggregated service policy prior to processing in an internal feature module, such as a crypto-engine. Packets on routers/switches are expected to be subjected to certain policies to address resource contention or streamlining/prioritization on outbound interfaces. Internal bottlenecks that a user can neither see nor control may cause packet transmission guarantees to be violated. Encryption is an example of an internal service that adds overhead thereby creating an internal bottleneck. Such internal bottlenecks are cured through intelligent means of pre-processing and pre-application of certain policy rules.
摘要翻译：描述在内部特征模块中处理分组之前识别和减轻瓶颈的方法和装置。首先，提供一种用于聚合各种物理接口的业务策略的方法，并且使用聚合结果来确定分组处理引擎是否能够满足聚合的服务策略信息。其次，在诸如密码引擎的内部特征模块中处理之前应用聚合服务策略的方法和装置。路由器/交换机上的数据包预计将受到某些策略的限制，以解决出站接口的资源争用或简化/优先级排序。用户既不能看到也不能控制的内部瓶颈可能会导致数据包传输保证被违反。加密是内部服务的一个例子，它会增加开销，从而创建内部瓶颈。这种内部瓶颈是通过预处理和预先应用某些策略规则的智能手段来治愈的。

8. 发明授权

US08652443B2 Foamable microemulsion compositions for topical administration 失效
标题翻译：用于局部给药的可发泡微乳液组合物
公开(公告)号：US08652443B2
公开(公告)日：2014-02-18
申请号：US12371155
申请日：2009-02-13
申请人： Ravi K. Varanasi , Roman V. Rariy
发明人： Ravi K. Varanasi , Roman V. Rariy
IPC分类号： A61K9/00 , A61K9/12 , A61K9/107
CPC分类号： A61K9/0014 , A61K9/122 , A61K9/124 , A61K31/164
摘要： Described are ethanol-free foamable microemulsions for topical application, and method of making them. The propellants used in the compositions may be environmentally-friendly hydrofluoroalkanes. The foam compositions may also comprise one or more of a variety of active ingredients, including anti-inflammatory agents, anesthetics, and keratolytic agents.
摘要翻译：描述了用于局部应用的无乙醇泡沫微乳液及其制备方法。在组合物中使用的推进剂可以是环保的氢氟烷烃。泡沫组合物还可以包含一种或多种各种活性成分，包括抗炎剂，麻醉剂和角质分解剂。

9. 发明申请

US20110142943A1 TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIODS AND OTHER DRUGS 有权
标题翻译：鸦片和其他药物的抗ANT药物组合物
公开(公告)号：US20110142943A1
公开(公告)日：2011-06-16
申请号：US12965572
申请日：2010-12-10
申请人： Roman V. Rariy , Alison B. Fleming , Jane C. Hirsh , Said Saim , Ravi K. Varanasi
发明人： Roman V. Rariy , Alison B. Fleming , Jane C. Hirsh , Said Saim , Ravi K. Varanasi
IPC分类号： A61K31/485 , A61K9/14 , A61P29/00
CPC分类号： A61K31/485 , A61K9/14 , A61K9/1617 , A61K9/1635 , A61K9/1641 , A61K9/1664 , A61K9/1694 , A61K9/4808 , A61K9/5042 , A61K47/12 , A61K47/44 , B29C70/60
摘要： Tamper-resistant pharmaceutical compositions have been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opioids. The tamper-resistant compositions retard the release of drug, even if the physical integrity of the formulation is compromised (for example, by chopping with a blade or crushing) and the resulting material is placed in water, snorted, or swallowed. However, when administered as directed, the drug is slowly released from the composition as the composition is passes through the GI tract.
摘要翻译：已经开发了防篡改的药物组合物，以减少不适当地施用药物，特别是诸如阿片样物质的药物的可能性。即使制剂的物理完整性受损（例如通过用刀片切碎或破碎），防篡改组合物也能延缓药物的释放，并将所得材料置于水中，嗅到或吞咽。然而，当按照指导给药时，当组合物通过胃肠道时，药物从组合物缓慢释放。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式